Healthcare Industry News: PET scan
News Release - March 9, 2010
Positron Corporation Cites JACR Study That Reports a 737% Growth Rate in PET among 5 Speciality Groups Including Cardiology
INDIANAPOLIS--(HSMN NewsFeed)--Positron Corporation (OTCBB:POSC ). The growth rate among nonradiologists who own or lease PET equipment was far higher than radiologists between 2002 and 2007, according to a study published in the March issue of the Journal of the American College of Radiology (JACR Volume 7, Issue 3, March 2010, Pages 187-191).The data for the study was collected utilizing the Medicare Part B Physician/Supplier Procedure Summary Master Files for 2002 through 2007.
The study states "Although a large percentage of PET scans in private offices are done by radiologists (45.4 percent in 2007), the growth rate among nonradiologists was far higher (737 percent) than radiologists (259 percent) between 2002 and 2007 and private-office PET market share for nonradiologists rose from 13 percent in 2002 to 24 percent in 2007”, according to Rajan Agarwal, MD and colleagues at the department of radiology, University of Pennsylvania Health System in Philadelphia.
“Five specialty groups accounted for 95 percent of all nonradiologist PET volume in 2007: internal medicine subspecialties (28,324 studies in 2007), medical oncology (14,320 studies), cardiology (13,724 studies), radiation oncology (9,563 studies), and primary care (2,398 studies), An additional contributing factor could be technical reimbursements for PET scans. Favorable technical-component reimbursements increase the profitability of scans performed on privately owned scanners, providing further incentive to nonradiologists to purchase PET scanners,” added Agarwal.
References: http://www.molecularimaging.net/index.php?option=com_articles&view=article&id=20924
About Positron: Positron is a molecular imaging company focused on Nuclear Cardiology. Positron utilizes its proprietary product line to provide unique solutions to the Nuclear Medicine community ranging from imaging systems to radiopharmaceutical distribution. Positron products include: the Attrius™, a PET imaging device; the Pulse®, a SPECT imaging device; the Nuclear Pharm-Assist®, an automated radiopharmaceutical distribution device; and the Tech-Assist™, a radiopharmaceutical injection shield. As a prominent player in the cardiac imaging industry, Positron maintains associations and relationships with multiple industry associations including the Academy of Molecular Imaging, American College of Cardiology American Society of Nuclear Cardiology and Society of Nuclear Medicine. Positron founded in 1983, is headquartered in Indianapolis, Indiana. More information about Positron is available at www.positron.com.
Forward Looking Statements: Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance and may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Positron Corporation to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission.
Source: Positron Corp
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
